Reperfusion Injury Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Reperfusion Injury clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery

Myocardial IschemiaHeart Valve DiseasesAortic Diseases+3 more
Muhammet Talha Ceran, MD80 enrolled1 locationNCT07249424
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)

Ischemia Reperfusion Injury
Bilix Co.,Ltd.40 enrolled5 locationsNCT07164833
Recruiting

OR6A2 on Monocytes and Cardiovascular Outcomes in Myocardial Ischemia-Reperfusion Injury

Myocardial Ischemia-Reperfusion Injury
Southeast University, China200 enrolled1 locationNCT07100457
Recruiting
Phase 1

Hydrogen's Feasibility and Safety as a Therapy in ECPR

Cardiac ArrestExtracorporeal Membrane OxygenationReperfusion Injury
Boston Children's Hospital53 enrolled4 locationsNCT05574296
Recruiting
Phase 2

Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI

Myocardial InfarctionReperfusion Injury, Myocardial
Ain Shams University76 enrolled1 locationNCT06564909
Recruiting
Not Applicable

Auricular Vagus Stimulation and STEMI

Acute Coronary SyndromeVagus Nerve StimulationIschemia Reperfusion Injury
Bakulev Scientific Center of Cardiovascular Surgery300 enrolled1 locationNCT05992259
Recruiting

OSA as a Remote Ischemic Preconditioning in Vascular Surgery

Obstructive Sleep ApneaIschemia Reperfusion InjuryVascular Aneurysm
St. Anne's University Hospital Brno, Czech Republic100 enrolled1 locationNCT04630535
Recruiting
Not Applicable

Remote Ischaemic Conditioning in STEMI Patients in AFRICA

Remote Ischaemic ConditioningSTEMIMyocardial Reperfusion Injury
University of Cape Town1,400 enrolled20 locationsNCT04813159
Recruiting
Phase 2

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Myocardial InjuryAcute Kidney InjuryIschemia Reperfusion Injury
Kaiser Permanente304 enrolled1 locationNCT04750616
Recruiting
Phase 2

Hypertonic Lactate After Cardiac Arrest

Cardiac ArrestIschemia Reperfusion InjuryAnoxic Brain Injury
Erasme University Hospital125 enrolled1 locationNCT05004610
Recruiting
Not Applicable

Trans-coronary Cooling and Dilution for Cardioprotection During Revascularisation for ST-elevation Myocardial Infarction

Myocardial InfarctionReperfusion Injury, Myocardial
Royal Brompton & Harefield NHS Foundation Trust60 enrolled1 locationNCT06128993
Recruiting
Phase 3

Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys

Kidney Transplant; ComplicationsIschemia Reperfusion InjuryDelayed Graft Function+1 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain60 enrolled1 locationNCT05430620
Recruiting
Phase 1Phase 2

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Ischemia Reperfusion InjuryDelayed Graft Function
Rhode Island Hospital20 enrolled1 locationNCT04005469
Recruiting
Phase 1

Mesenchymal Stem Cells (MSC) for the amelioration of ischaemia-reperfusion injury (IRI) after deceased donor renal transplantation, a phase 1 pilot study

Ischaemia reperfusion injuryKidney Transplantation
Royal Perth Hospital10 enrolled1 locationACTRN12615000678594